FR2125248B1 - - Google Patents

Info

Publication number
FR2125248B1
FR2125248B1 FR7120247A FR7120247A FR2125248B1 FR 2125248 B1 FR2125248 B1 FR 2125248B1 FR 7120247 A FR7120247 A FR 7120247A FR 7120247 A FR7120247 A FR 7120247A FR 2125248 B1 FR2125248 B1 FR 2125248B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7120247A
Other versions
FR2125248A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Publication of FR2125248A1 publication Critical patent/FR2125248A1/fr
Application granted granted Critical
Publication of FR2125248B1 publication Critical patent/FR2125248B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7120247A 1971-02-12 1971-06-03 Expired FR2125248B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11504571A 1971-02-12 1971-02-12

Publications (2)

Publication Number Publication Date
FR2125248A1 FR2125248A1 (fr) 1972-09-29
FR2125248B1 true FR2125248B1 (fr) 1975-08-01

Family

ID=22358997

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120247A Expired FR2125248B1 (fr) 1971-02-12 1971-06-03

Country Status (8)

Country Link
US (1) US3751404A (fr)
JP (1) JPS5414103B1 (fr)
AT (1) AT333986B (fr)
DE (1) DE2127393C3 (fr)
ES (1) ES391701A1 (fr)
FR (1) FR2125248B1 (fr)
IL (1) IL36869A (fr)
PH (3) PH13821A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907762A (en) * 1971-12-27 1975-09-23 Univ Sherbrooke Angiotensin{hd II {B position 8 analogs
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2
HU191961B (en) * 1984-08-02 1987-04-28 Richter Gedeon Vegyeszet Process for producing 1,5 and 8 substituted peptides of angiotenzin-ii antagonistic activity
ZA9010460B (en) * 1989-12-29 1992-11-25 Univ Technologies Int Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin
WO1991010140A2 (fr) * 1989-12-29 1991-07-11 University Technologies International Inc. Methodes de modelage des structures tertiaires de ligands biologiquement actifs, y compris leurs agonistes et antagonistes et nouveaux antagonistes synthetiques bases sur l'angiotensine
PT2376101E (pt) 2008-12-29 2016-02-04 Trevena Inc Efectores da beta-arrestina e composições e métodos para a sua utilização
EP3102223A4 (fr) 2014-02-07 2017-11-29 Trevena, Inc. Formes cristallines et amorphes d'un effecteur bêta-arrestine
US9611293B2 (en) 2014-05-19 2017-04-04 Trevena, Inc. Synthesis of beta-arrestin effectors
JP7026575B2 (ja) 2018-05-22 2022-02-28 株式会社ニューフレアテクノロジー 電子ビーム照射方法、電子ビーム照射装置、及びプログラム

Also Published As

Publication number Publication date
PH17092A (en) 1984-05-29
PH17100A (en) 1984-05-29
IL36869A0 (en) 1971-07-28
ES391701A1 (es) 1973-06-16
FR2125248A1 (fr) 1972-09-29
IL36869A (en) 1974-11-29
PH13821A (en) 1980-10-03
DE2127393B2 (de) 1979-09-20
AT333986B (de) 1976-12-27
DE2127393C3 (de) 1980-07-10
ATA483471A (de) 1976-04-15
JPS5414103B1 (fr) 1979-06-05
US3751404A (en) 1973-08-07
DE2127393A1 (de) 1972-09-07

Similar Documents

Publication Publication Date Title
FR2125248B1 (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU3005371A (fr)
AU2894671A (fr)
AU2485671A (fr)
AU2742671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AR192311Q (fr)
AU2938071A (fr)
AU2706571A (fr)
AU2724971A (fr)
AU2726271A (fr)
AU2740271A (fr)
AR202997Q (fr)
AU2654071A (fr)
AU2415871A (fr)
AU2755871A (fr)
AU3038671A (fr)
AU3025871A (fr)
AU2836771A (fr)
AU2588771A (fr)
AU2963771A (fr)
AU2473671A (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property